Pages that link to "Q26776237"
The following pages link to Chronic, intermittent convection-enhanced delivery devices (Q26776237):
Displaying 15 items.
- Intrastriatally Infused Exogenous CDNF Is Endocytosed and Retrogradely Transported to Substantia Nigra (Q37654138) (← links)
- Insights from mathematical modeling for convection-enhanced intraputamenal delivery of GDNF. (Q38703977) (← links)
- Theory of porous catheters and their applications in intraparenchymal infusions. (Q47555675) (← links)
- GABA-containing liposomes: neuroscience applications and translational perspectives for targeting neurological diseases. (Q47763656) (← links)
- Miniaturized neural system for chronic, local intracerebral drug delivery. (Q47841400) (← links)
- A Microfluidic Ion Pump for In Vivo Drug Delivery. (Q48146443) (← links)
- Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models (Q50090665) (← links)
- Convection-enhanced delivery: chemosurgery in diffuse intrinsic pontine glioma. (Q55456546) (← links)
- Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery. (Q55456554) (← links)
- Electrophoretic drug delivery for seizure control (Q58695880) (← links)
- Therapies to Slow, Stop, or Reverse Parkinson's Disease (Q60950144) (← links)
- Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease (Q64099472) (← links)
- Treatment Strategies in Diffuse Midline Gliomas With the H3K27M Mutation: The Role of Convection-Enhanced Delivery in Overcoming Anatomic Challenges (Q64244053) (← links)
- Boron delivery agents for neutron capture therapy of cancer (Q89141802) (← links)
- CDNF Protein Therapy in Parkinson's Disease (Q92853694) (← links)